Insider Trading & Ownership of Peter A. Thompson

Location: New York, NY
Summary: The estimated net worth of Peter A. Thompson is at least $198,758,201 dollars as of 29 Dec 2025. Peter A. Thompson is the Director of Sionna Therapeutics, Inc. and owns shares of Sionna Therapeutics, Inc. (SION) stock worth about $158.67M. Peter A. Thompson is the Director, 10%+ Owner of Corvus Pharmaceuticals, Inc. and owns shares of Corvus Pharmaceuticals, Inc. (CRVS) stock worth about $29.8M. Peter A. Thompson is the Director, 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $8.93M. Peter A. Thompson is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $1.36M.
Signature: /s/ Peter A. Thompson
All Insider Reports: All Insider Reports

Notify me when Peter A. Thompson files a new Insider Trading report.

Ownership of Peter A. Thompson

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SION	Sionna Therapeutics, Inc.	Director	$158,671,730	-$6,383,642	-3.9%	24 Dec 2025
CRVS	Corvus Pharmaceuticals, Inc.	Director, 10%+ Owner	$29,796,393	-$4,891,894	-14%	27 Jun 2025
EWTX	Edgewise Therapeutics, Inc.	Director, 10%+ Owner	$8,933,533	+$10,000,000		16 Jun 2025
JANX	Janux Therapeutics, Inc.	Director	$1,356,545			14 Jun 2022
ALPN	ALPINE IMMUNE SCIENCES, INC.	Director	$0			18 May 2024
SPRY	ARS Pharmaceuticals, Inc.	Director	$0			25 Jun 2025
DBTX	Decibel Therapeutics, Inc.	Director, 10%+ Owner				17 Jun 2022
PMVP	PMV Pharmaceuticals, Inc.	Director, 10%+ Owner				02 Jun 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.